Low Back Pain
Conditions
Interventions
This is a longitudinal, experimental study, designed as an open-label, randomized controlled clinical trial with two arms. The experimental group will consist of 60 older adults of both sexes with chr
E02.760.169.063.500.387
E02.760.169.063.500
Sponsors
Universidade Federal de Juiz de Fora - UFJF
Universidade Federal de Juiz de Fora - UFJF
Eligibility
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: Aged 60 years or older; both sexes; report chronic low back pain, defined as the presence of symptoms in the lumbar region for a period longer than three months; present a score of four or higher on the Roland-Morris Disability Questionnaire and pain intensity greater than three on the Visual Analog Scale (VAS)
Exclusion criteria
Exclusion criteria: Individuals presenting with radiculopathies; severe spinal pathologies such as cauda equina syndrome, fractures, or cancer; history of spinal surgery within the past 12 months; signs of cognitive impairment; pregnancy; or absolute and relative contraindications to exercise, as described in the guidelines of the American College of Sports Medicine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected Outcome 1: A reduction in reported pain intensity is expected over a period of three and six months, as measured by the Visual Analog Scale (VAS), based on the observation of a variation of at least two points between pre- and post-intervention;Expected Outcome 2: A reduction in self-reported functional disability is expected to be observed in the three- and six-month follow-up assessments, as measured by the Roland-Morris Disability Questionnaire, based on a minimum change of five points between the pre- and post-intervention assessments | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected Outcome 1: An improvement in self-reported quality of life is expected to be observed in the three- and six-month follow-up assessments, as measured by the SF-12, based on a minimum change of 3.3 points between the pre- and post-intervention assessments;Expected Outcome 2: A reduction in self-reported fear of falling is expected to be observed in the three- and six-month follow-up assessments, as measured by the Falls Efficacy Scale – International (FES-I), with a total score between 16 and 19, corresponding to a "low fear of falling" ;Expected Outcome 3: A self-reported clinical improvement is expected to be observed in the three- and six-month follow-up assessments, as measured by the Global Perceived Effect (GPE) Scale. Improvement will be considered clinically important starting from the category "a little better," reflecting the minimal clinically important difference (MCID) for patients with chronic low back pain | — |
Countries
Brazil
Contacts
Public ContactPriscylla Freire
Universidade Federal de Juiz de Fora (UFJF)
Outcome results
None listed